Literature DB >> 26234755

Plasma amyloid β-quo vadis?

Henrik Zetterberg1.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 26234755     DOI: 10.1016/j.neurobiolaging.2015.07.021

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


× No keyword cloud information.
  9 in total

Review 1.  Applying fluid biomarkers to Alzheimer's disease.

Authors:  Henrik Zetterberg
Journal:  Am J Physiol Cell Physiol       Date:  2017-04-19       Impact factor: 4.249

Review 2.  Amyloid-β and Parkinson's disease.

Authors:  Ee Wei Lim; Dag Aarsland; Dominic Ffytche; Raquel Natalia Taddei; Daniel J van Wamelen; Yi-Min Wan; Eng King Tan; Kallol Ray Chaudhuri
Journal:  J Neurol       Date:  2018-10-30       Impact factor: 4.849

3.  Plasmalemmal VDAC-1 corroborated as amyloid Aß-receptor.

Authors:  Friedrich P Thinnes
Journal:  Front Aging Neurosci       Date:  2015-09-30       Impact factor: 5.750

Review 4.  Molecular biomarkers of Alzheimer's disease: progress and prospects.

Authors:  Tammaryn Lashley; Jonathan M Schott; Philip Weston; Christina E Murray; Henny Wellington; Ashvini Keshavan; Sandrine C Foti; Martha Foiani; Jamie Toombs; Jonathan D Rohrer; Amanda Heslegrave; Henrik Zetterberg
Journal:  Dis Model Mech       Date:  2018-05-08       Impact factor: 5.758

Review 5.  Utility of Animal Models to Understand Human Alzheimer's Disease, Using the Mastermind Research Approach to Avoid Unnecessary Further Sacrifices of Animals.

Authors:  Tian Qin; Samantha Prins; Geert Jan Groeneveld; Gerard Van Westen; Helga E de Vries; Yin Cheong Wong; Luc J M Bischoff; Elizabeth C M de Lange
Journal:  Int J Mol Sci       Date:  2020-04-30       Impact factor: 5.923

6.  A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's disease.

Authors:  Nicholas J Ashton; Alejo J Nevado-Holgado; Imelda S Barber; Steven Lynham; Veer Gupta; Pratishtha Chatterjee; Kathryn Goozee; Eugene Hone; Steve Pedrini; Kaj Blennow; Michael Schöll; Henrik Zetterberg; Kathryn A Ellis; Ashley I Bush; Christopher C Rowe; Victor L Villemagne; David Ames; Colin L Masters; Dag Aarsland; John Powell; Simon Lovestone; Ralph Martins; Abdul Hye
Journal:  Sci Adv       Date:  2019-02-06       Impact factor: 14.136

7.  Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration.

Authors:  Nicholas J Ashton; Antoine Leuzy; Yau Mun Lim; Claire Troakes; Tibor Hortobágyi; Kina Höglund; Dag Aarsland; Simon Lovestone; Michael Schöll; Kaj Blennow; Henrik Zetterberg; Abdul Hye
Journal:  Acta Neuropathol Commun       Date:  2019-01-09       Impact factor: 7.801

Review 8.  Blood-based biomarker in Parkinson's disease: potential for future applications in clinical research and practice.

Authors:  Lars Tönges; Carsten Buhmann; Stephan Klebe; Jochen Klucken; Eun Hae Kwon; Thomas Müller; David J Pedrosa; Nils Schröter; Peter Riederer; Paul Lingor
Journal:  J Neural Transm (Vienna)       Date:  2022-04-15       Impact factor: 3.850

Review 9.  In vivo Detection of Alzheimer's Disease.

Authors:  Antoine Leuzy; Kerstin Heurling; Nicholas J Ashton; Michael Schöll; Eduardo R Zimmer
Journal:  Yale J Biol Med       Date:  2018-09-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.